Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Varenhorst (NPI 1730180886)

Field	Value
Entity Type	Individual
Organization	Michael Varenhorst
Address	530 N Lorraine St
City	Wichita
State	KS
ZIP	67214
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	August 10, 2005

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice whose Medicare revenue is dominated by intravitreal biologic injections: J0178, J2778, and J2777 together account for 83.2% of total Medicare revenue. The three top codes generate $1.5M (J0178, 43.9%), $914.8K (J2778, 26.6%), and $433.3K (J2777, 12.6%) respectively, indicating a business model centered on high-volume anti-VEGF and related biologic therapy for retinal disease.

The revenue profile shows heavy concentration: total Medicare revenue is $3.4M and the top 3 codes by revenue account for 83.2% of that Medicare revenue. This concentration suggests the practice derives most of its Medicare income from repeat, pharmacologic retinal treatments rather than diversified outpatient or procedural lines.

On competitive standing, the provider is a clear national high-volume outlier for ranibizumab (J2778): 5.1K claims, $181 avg paid/claim, $914.8K revenue and a national rank of #43 of 1208 (97th percentile; notably above typical national volume). That rank indicates this clinician is a major national user of J2778 relative to peers, which may reflect treatment preference, formulary access, or local referral patterns.

By contrast, J0178 ($1.5M revenue, 2.2K claims, $692 avg paid/claim) ranks #445 of 3204 nationally (86th percentile; typical, unremarkable volume) and J2777 (14.9K claims, $29 avg paid/claim, $433.3K revenue) ranks #716 of 2039 (65th percentile; typical, unremarkable volume). These ranks show that while J0178 is the single largest revenue line, its national volume standing is not exceptional, and J2777 produces substantial claim counts but lower average payment per claim.

The practice is an extreme outlier on certain diagnostic and E/M metrics: 92134 has 2.8K claims and $72.5K revenue with a national rank of #494 of 26868 (98th percentile; extreme outlier), and 99213 has 1.3K claims and $71.9K revenue with a national rank of #3535 of 457151 (99th percentile; extreme outlier). These outsized ranks for retinal imaging and low‑level established E/M suggest very high patient throughput for retina follow-up and monitoring relative to national peers.

Procedural billing outside drug administration is also notable: 67028 shows 2.1K claims and $181.3K revenue (5.3% of Medicare revenue) with a national rank of #348 of 4255 (92th percentile; notably above typical national volume). This indicates a substantial volume of isolated intravitreal injection procedures billed as separate services in addition to drug administration codes.

Payer mix is effectively single‑payer Medicare: lifetime Medicare revenue is $3.4M and there is no Medicaid billing on file. The absence of Medicaid activity means analyses of this provider should treat Medicare as the operational and financial primary payer.

The provider’s NPI was enumerated on 2005-08-10 (~21 years ago), indicating long tenure in the Medicare program; this sustained enrollment combined with concentrated anti-VEGF billing implies an established retinal referral base and stable, treatment‑focused practice operations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,180	$690	$1.5M
J2778	Injection, ranibizumab, 0.1 mg	5,050	$180	$914.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	14,940	$30	$433.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,110	$90	$181.3K
J0179	Injection, brolucizumab-dbll, 1 mg	700	$250	$172.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,790	$30	$72.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,260	$60	$71.9K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	20	$860	$16.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	150	$110	$15.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	150	$80	$12.4K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Michael Varenhorst — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	7	30	1,770	$690	$1.3M
J2777	9	30	12,060	$30	$575.7K
J2778	2	20	860	$180	$297.6K
J0179	1	10	700	$250	$172.9K
67028	8	40	1,170	$90	$111.4K
67042	20	20	20	$1,140	$31.9K
67108	7	20	20	$1,130	$24.8K
J3590	21	20	200	$100	$24.1K
92014	292	530	180	$70	$18.5K
99214	3,662	4,310	120	$70	$16.4K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Varenhorst, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Michael Varenhorst, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Craig Resources LLC	KS	Home Health Agency	$0	$97.3M
Paradigm Services Inc	KS	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$42.4M
Wesley Medical Center LLC	KS	General Acute Care Hospital	$0	$30.2M
Gracemed Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$18.3M
Healthcore Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$15.3M
Diversified Family Services LLC	KS	Home Health Agency	$0	$13.9M
Alpha Service	KS	Developmentally Disabled Services Day Training Agency	$0	$12.1M
Carepoint Emergency Medicine Kansas LLC	KS	Emergency Medicine Physician	$0	$11.8M
Hunter Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$10.4M
Ascension Via Christi Hospitals Wichita Inc.	KS	General Acute Care Hospital	$0	$8.9M

Michael Varenhorst — Billing Profile & Reimbursement Data

Sign up for Michael Varenhorst — Billing Profile & Reimbursement Data policy alerts

Michael Varenhorst — Billing Profile & Reimbursement Data

Sign up for Michael Varenhorst — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References